Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $64.00 for the day, up 15.92% from the previous closing price of $55.21. In other words, the price has increased by $15.92 from its previous closing price. On the day, 77.07 million shares were traded.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.89. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On February 18, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also upped its target price recommendation from $42 to $60.
Citigroup Downgraded its Neutral to Sell on January 10, 2025, whereas the target price for the stock was revised from $24 to $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 12 ’25 when Baird Melissa sold 33,333 shares for $56.02 per share. The transaction valued at 1,867,376 led to the insider holds 805,083 shares of the business.
Boughton Soleil sold 3,235 shares of HIMS for $181,160 on May 12 ’25. The Chief Legal Officer now owns 156,427 shares after completing the transaction at $56.00 per share. On May 12 ’25, another insider, Melissa Baird, who serves as the Officer of the company, bought 33,333 shares for $55.21 each.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 93.16, and their Forward P/E ratio for the next fiscal year is 65.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.03 while its Price-to-Book (P/B) ratio in mrq is 26.05.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $12.07. The 50-Day Moving Average of the stock is 85.48%, while the 200-Day Moving Average is calculated to be 127.96%.
Shares Statistics:
A total of 215.21M shares are outstanding, with a floating share count of 183.50M. Insiders hold about 18.02% of the company’s shares, while institutions hold 71.79% stake in the company.
